30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Cano Health Inc (CANO)

Stock chart
Ticker: CANO Exchange: NYS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Cooperstone Elliot
1 sale — total 2,780 USD
Sale 1 Feb 2024
Value US$3,511,081.88 | Price 23.93 | Shares 97,811
Sale 31 Jan 2024
Value US$2,147,120.82 | Price 49.41 | Shares 20,913
Sale 30 Jan 2024
Value US$34,285.40 | Price 2.70 | Shares 12,703
Sale 29 Jan 2024
Value US$113,471.20 | Price 2.74 | Shares 41,357
Sale 26 Jan 2024
Value US$89,735.75 | Price 2.74 | Shares 32,693
Sale 25 Jan 2024
Value US$47,960.01 | Price 2.58 | Shares 18,569
Sale 24 Jan 2024
Value US$101,612.36 | Price 2.84 | Shares 35,808
Sale 23 Jan 2024
Value US$214,800.30 | Price 2.94 | Shares 73,034
Sale 22 Jan 2024
Value US$312,762.50 | Price 2.50 | Shares 125,000
Sale 18 Jan 2024
Value US$191,250.00 | Price 1.91 | Shares 100,000
Sale 17 Jan 2024
Value US$17,489.22 | Price 2.92 | Shares 5,987
Sale 17 Jan 2024
Value US$214,058.20 | Price 2.28 | Shares 94,013
Proposed sale 17 Jan 2024
Value US$2,162,000.00 | Price 3.00 | Shares 720,876
Sale 12 Jan 2024
Value US$79,877.90 | Price 3.30 | Shares 24,171
Sale 11 Jan 2024
Value US$89,790.00 | Price 3.59 | Shares 25,000
Sale 10 Jan 2024
Value US$93,292.50 | Price 3.73 | Shares 25,000
Sale 9 Jan 2024
Value US$93,672.50 | Price 3.75 | Shares 25,000
Sale 8 Jan 2024
Value US$95,552.50 | Price 3.82 | Shares 25,000
Sale 5 Jan 2024
Value US$96,232.50 | Price 3.85 | Shares 25,000
Sale 4 Jan 2024
Value US$53,297.34 | Price 4.00 | Shares 13,328
Sale 3 Jan 2024
Value US$119,422.81 | Price 4.94 | Shares 24,182
Sale 3 Jan 2024
Value US$207,251.05 | Price 4.08 | Shares 50,818
Sale 2 Jan 2024
Value US$235,657.88 | Price 5.42 | Shares 43,505
Sale 29 Dec 2023
Value US$210,643.91 | Price 6.00 | Shares 35,112
Sale 28 Dec 2023
Value US$247,227.32 | Price 6.00 | Shares 41,197
Sale 27 Dec 2023
Value US$212,370.49 | Price 5.65 | Shares 37,607
Sale 26 Dec 2023
Value US$115,124.30 | Price 5.44 | Shares 21,154
Sale 22 Dec 2023
Value US$154,786.82 | Price 5.65 | Shares 27,377
Sale 21 Dec 2023
Value US$41,764.95 | Price 6.62 | Shares 6,309
Sale 21 Dec 2023
Value US$469,429.86 | Price 5.67 | Shares 82,843
Proposed sale 21 Dec 2023
Value US$5,902,000.00 | Price 11.08 | Shares 532,603
Proposed sale 7 Dec 2023
Value US$2,123,343.00 | Price 12.05 | Shares 176,211
Sale 11 Aug 2023
Value US$23,453.38 | Price 0.77 | Shares 30,646
Proposed sale 29 Jun 2023
Value US$525,745.00 | Price 1.31 | Shares 400,000
Proposed sale 28 Jun 2023
Value US$183,300.00 | Price 1.22 | Shares 150,000
Sale 12 Jun 2023
Value US$711,650.00 | Price 1.42 | Shares 500,000
Proposed sale 12 Jun 2023
Value US$711,650.00 | Price 1.42 | Shares 500,000
Sale 9 Jun 2023
Value US$137,760.00 | Price 1.38 | Shares 100,000
Proposed sale 9 Jun 2023
Value US$137,760.00 | Price 1.38 | Shares 100,000
Sale 8 Jun 2023
Value US$356,155.76 | Price 1.29 | Shares 275,940
Proposed sale 8 Jun 2023
Value US$355,962.60 | Price 1.29 | Shares 275,940
Sale 7 Jun 2023
Value US$528,400.00 | Price 1.32 | Shares 400,000
Proposed sale 7 Jun 2023
Value US$528,400.00 | Price 1.32 | Shares 400,000
Sale 6 Jun 2023
Value US$4,351.02 | Price 1.38 | Shares 3,163
Sale 5 Apr 2023
Value US$30,066.73 | Price 1.27 | Shares 23,591
Buy 17 Mar 2022
Value US$2,043,000.00 | Price 6.81 | Shares 300,000
Buy 6 Dec 2021
Value US$120,000.00 | Price 8.00 | Shares 15,000
Buy 3 Dec 2021
Value US$109,375.00 | Price 8.75 | Shares 12,500
Buy 22 Nov 2021
Value US$77,200.00 | Price 9.65 | Shares 8,000
Buy 18 Nov 2021
Value US$1,023,350.00 | Price 10.55 | Shares 97,000
Buy 31 Aug 2021
Value US$29,975.00 | Price 11.99 | Shares 2,500
Buy 31 Aug 2021
Value US$69,937.67 | Price 11.99 | Shares 5,833
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-02 2024-02-01 S Sale Large shareholder
97,811 -14.0%
23.93
US$3,511,082
97,811 -14.0% 23.93 US$3,511,082
2024-02-02 2024-01-31 S Sale Large shareholder
20,913 -26.2%
49.41
US$2,147,121
20,913 -26.2% 49.41 US$2,147,121
2024-02-02 2024-01-30 S Sale Large shareholder
62,139 -38.5%
328.31
US$67,353
62,139 -38.5% 328.31 US$67,353
2024-01-29 2024-01-29 S Sale Large shareholder
41,357 -7.1%
2.74
US$113,471
41,357 -7.1% 2.74 US$113,471
2024-01-29 2024-01-26 S Sale Large shareholder
32,693 -5.3%
2.74
US$89,736
32,693 -5.3% 2.74 US$89,736
2024-01-29 2024-01-25 S Sale Large shareholder
18,569 -2.9%
2.58
US$47,960
18,569 -2.9% 2.58 US$47,960
2024-01-24 2024-01-24 S Sale Large shareholder
35,808 -5.4%
2.84
US$101,612
35,808 -5.4% 2.84 US$101,612
2024-01-24 2024-01-23 S Sale Large shareholder
73,034 -9.9%
2.94
US$214,800
73,034 -9.9% 2.94 US$214,800
2024-01-24 2024-01-22 S Sale Large shareholder
125,000 -14.4%
2.50
US$312,762
125,000 -14.4% 2.50 US$312,762
2024-01-19 2024-01-18 S Sale Large shareholder
100,000 -10.4%
1.91
US$191,250
100,000 -10.4% 1.91 US$191,250
2024-01-19 2024-01-17 S Sale Large shareholder
5,987 -0.6%
2.92
US$17,489
5,987 -0.6% 2.92 US$17,489
2024-01-19 2024-01-17 S Sale Large shareholder
94,013 -8.8%
2.28
US$214,058
94,013 -8.8% 2.28 US$214,058
2024-01-17 2024-01-17 PrS Proposed sale

10% Stockholder

Large shareholder
720,876
3.00
US$2,162,000
720,876 3.00 US$2,162,000
2024-01-12 2024-01-12 S Sale Large shareholder
24,171 -100.0%
3.30
US$79,878
24,171 -100.0% 3.30 US$79,878
2024-01-12 2024-01-11 S Sale Large shareholder
25,000 -50.8%
3.59
US$89,790
25,000 -50.8% 3.59 US$89,790
2024-01-12 2024-01-10 S Sale Large shareholder
25,000 -33.7%
3.73
US$93,292
25,000 -33.7% 3.73 US$93,292
2024-01-09 2024-01-09 S Sale Large shareholder
25,000 -25.2%
3.75
US$93,672
25,000 -25.2% 3.75 US$93,672
2024-01-09 2024-01-08 S Sale Large shareholder
25,000 -20.1%
3.82
US$95,552
25,000 -20.1% 3.82 US$95,552
2024-01-09 2024-01-05 S Sale Large shareholder
25,000 -16.8%
3.85
US$96,232
25,000 -16.8% 3.85 US$96,232
2024-01-04 2024-01-04 S Sale Large shareholder
13,328 -8.2%
4.00
US$53,297
13,328 -8.2% 4.00 US$53,297
2024-01-04 2024-01-03 S Sale Large shareholder
24,182 -13.0%
4.94
US$119,423
24,182 -13.0% 4.94 US$119,423
2024-01-04 2024-01-03 S Sale Large shareholder
50,818 -21.4%
4.08
US$207,251
50,818 -21.4% 4.08 US$207,251
2024-01-04 2024-01-02 S Sale Large shareholder
43,505 -15.5%
5.42
US$235,658
43,505 -15.5% 5.42 US$235,658
2023-12-29 2023-12-29 S Sale Large shareholder
35,112 -11.1%
6.00
US$210,644
35,112 -11.1% 6.00 US$210,644
2023-12-29 2023-12-28 S Sale Large shareholder
41,197 -11.5%
6.00
US$247,227
41,197 -11.5% 6.00 US$247,227
2023-12-29 2023-12-27 S Sale Large shareholder
37,607 -9.5%
5.65
US$212,370
37,607 -9.5% 5.65 US$212,370
2023-12-26 2023-12-26 S Sale Large shareholder
21,154 -5.1%
5.44
US$115,124
21,154 -5.1% 5.44 US$115,124
2023-12-26 2023-12-22 S Sale Large shareholder
27,377 -6.2%
5.65
US$154,787
27,377 -6.2% 5.65 US$154,787
2023-12-26 2023-12-21 S Sale Large shareholder
6,309 -1.4%
6.62
US$41,765
6,309 -1.4% 6.62 US$41,765
2023-12-26 2023-12-21 S Sale Large shareholder
82,843 -15.6%
5.67
US$469,430
82,843 -15.6% 5.67 US$469,430
2023-12-21 2023-12-21 PrS Proposed sale

10% Stockholder

Large shareholder
532,603
11.08
US$5,902,000
532,603 11.08 US$5,902,000
2023-12-07 2023-12-07 PrS Proposed sale

Affiliate

176,211
12.05
US$2,123,343
176,211 12.05 US$2,123,343
2023-08-15 2023-08-11 S Sale

Chief Operating Officer

Officer
30,646 -0.1%
0.77
US$23,453
30,646 -0.1% 0.77 US$23,453
2023-06-29 2023-06-29 PrS Proposed sale

Director

Non-Executive Director
400,000
1.31
US$525,745
400,000 1.31 US$525,745
2023-06-28 2023-06-28 PrS Proposed sale

Director

Non-Executive Director
150,000
1.22
US$183,300
150,000 1.22 US$183,300
2023-06-13 2023-06-12 S Sale

Chief Clinical Officer

Officer
500,000 -29.2%
1.42
US$711,650
500,000 -29.2% 1.42 US$711,650
2023-06-12 2023-06-12 PrS Proposed sale

Director

Non-Executive Director
500,000
1.42
US$711,650
500,000 1.42 US$711,650
2023-06-13 2023-06-09 S Sale

Chief Clinical Officer

Officer
100,000 -5.5%
1.38
US$137,760
100,000 -5.5% 1.38 US$137,760
2023-06-09 2023-06-09 PrS Proposed sale

Director

Non-Executive Director
100,000
1.38
US$137,760
100,000 1.38 US$137,760
2023-06-13 2023-06-08 S Sale

Chief Clinical Officer

Officer
275,940 -13.2%
1.29
US$356,156
275,940 -13.2% 1.29 US$356,156
2023-06-08 2023-06-08 PrS Proposed sale

Director

Non-Executive Director
275,940
1.29
US$355,963
275,940 1.29 US$355,963
2023-06-13 2023-06-07 S Sale

Chief Clinical Officer

Officer
400,000 -21.2%
1.32
US$528,400
400,000 -21.2% 1.32 US$528,400
2023-06-07 2023-06-07 PrS Proposed sale

Director

Non-Executive Director
400,000
1.32
US$528,400
400,000 1.32 US$528,400
2023-06-07 2023-06-06 S Sale

See remarks

Officer
3,163 -0.5%
1.38
US$4,351
3,163 -0.5% 1.38 US$4,351
2023-04-07 2023-04-05 S Sale

Chief Financial Officer

Officer
23,591 -2.9%
1.27
US$30,067
23,591 -2.9% 1.27 US$30,067
2022-03-21 2022-03-17 B Purchase Non-Executive Director
300,000 +2023.6%
6.81
US$2,043,000
300,000 +2023.6% 6.81 US$2,043,000
2021-12-07 2021-12-06 B Purchase

CEO and President

Executive Director
15,000 +0.5%
8.00
US$120,000
15,000 +0.5% 8.00 US$120,000
2021-12-06 2021-12-03 B Purchase

CEO and President

Executive Director
12,500 +0.4%
8.75
US$109,375
12,500 +0.4% 8.75 US$109,375
2021-11-24 2021-11-22 B Purchase

CEO and President

Executive Director
8,000 +0.3%
9.65
US$77,200
8,000 +0.3% 9.65 US$77,200
2021-11-30 2021-11-18 B Purchase Non-Executive Director
97,000 +inf%
10.55
US$1,023,350
97,000 +inf% 10.55 US$1,023,350
2021-09-02 2021-08-31 B Purchase

CEO and President

Executive Director
2,500 +3.8%
11.99
US$29,975
2,500 +3.8% 11.99 US$29,975
2021-09-02 2021-08-31 B Purchase

CEO and President

Executive Director
5,833 +0.4%
11.99
US$69,938
5,833 +0.4% 11.99 US$69,938